Chemours Board Sued In Del. For Undisclosed Toxic Tabs
A Chemours Co. stockholder sued the company's board and top officers in Chancery Court seeking derivative damages for nearly $1.74 billion in Chemours share repurchases and dividends despite a crushing and...To view the full article, register now.
Already a subscriber? Click here to view full article